Real-Time Loop-Mediated Isothermal Amplification (RealAmp) for the Species-Specific Identification of Plasmodium vivax
Genre
Journal ArticleDate
2013-01-29Author
Patel, JCOberstaller, J
Xayavong, M
Narayanan, J
DeBarry, JD
Srinivasamoorthy, G
Villegas, L
Escalante, AA
DaSilva, A
Peterson, DS
Barnwell, JW
Kissinger, JC
Udhayakumar, V
Lucchi, NW
Subject
HumansMalaria, Vivax
Nucleic Acid Amplification Techniques
Plasmodium vivax
RNA, Ribosomal, 18S
Sensitivity and Specificity
Species Specificity
Permanent link to this record
http://hdl.handle.net/20.500.12613/5416
Metadata
Show full item recordDOI
10.1371/journal.pone.0054986Abstract
Plasmodium vivax infections remain a major source of malaria-related morbidity and mortality. Early and accurate diagnosis is an integral component of effective malaria control programs. Conventional molecular diagnostic methods provide accurate results but are often resource-intensive, expensive, have a long turnaround time and are beyond the capacity of most malaria-endemic countries. Our laboratory has recently developed a new platform called RealAmp, which combines loop-mediated isothermal amplification (LAMP) with a portable tube scanner real-time isothermal instrument for the rapid detection of malaria parasites. Here we describe new primers for the detection of P. vivax using the RealAmp method. Three pairs of amplification primers required for this method were derived from a conserved DNA sequence unique to the P. vivax genome. The amplification was carried out at 64°C using SYBR Green or SYTO-9 intercalating dyes for 90 minutes with the tube scanner set to collect fluorescence signals at 1-minute intervals. Clinical samples of P. vivax and other human-infecting malaria parasite species were used to determine the sensitivity and specificity of the primers by comparing with an 18S ribosomal RNA-based nested PCR as the gold standard. The new set of primers consistently detected laboratory-maintained isolates of P. vivax from different parts of the world. The primers detected P. vivax in the clinical samples with 94.59% sensitivity (95% CI: 87.48-98.26%) and 100% specificity (95% CI: 90.40-100%) compared to the gold standard nested-PCR method. The new primers also proved to be more sensitive than the published species-specific primers specifically developed for the LAMP method in detecting P. vivax.Citation to related work
Public Library of Science (PLoS)Has part
PLoS ONEADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/5398
Scopus Count
Collections
Except where otherwise noted, this item's license is described as https://creativecommons.org/publicdomain/zero/1.0/